News
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
Insurance coverage for weight-loss drugs has recently increased, but typically only covers branded versions, according to ...
GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...
Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug ...
There have been hundreds of cases of acute pancreatitis in people who have also taken Mounjaro, Ozempic and Wegovy.
India Today on MSN56m
Miracle or myth? Sneha Mordani decodes weight-loss drugs with Dr Ambrish MithalAre GLP-1 weight-loss drugs a medical breakthrough or a ticking time bomb? The debate is louder than ever— hailed by some as ...
As Ohio cuts off state employees' coverage of medications for weight loss, a lawmaker who has benefited from the drugs wants to bring them back.
At least 10 people have now died following side-effects allegedly caused by GLP-1 weight loss jabs. Over a million people ...
1h
India Today on MSNSide effects to surprises: Dr Ambrish Mithal on India's weight-loss drug revolutionDr. Ambish Mithal unpacks the world of new-age weight management drugs, their side effects, their benefits and what lies ...
23h
India Today on MSNAll you need to know about weight-loss surgery and medicationsWeight-loss drugs offer initial benefits but often lead to weight regain after discontinuation. Bariatric surgery provides ...
With Mounjaro being rolled out at GPs down south, experts have listed the reasons why people getting the jabs may still not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results